CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: trazodone
Accession: CHEBI:9654
browse the term
Definition: An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.
Synonyms: exact_synonym: 2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one
related_synonym: 2-(3-[4-(3-chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one; Formula=C19H22ClN5O; InChI=1S/C19H22ClN5O/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25/h1-3,5-7,9,15H,4,8,10-14H2; InChIKey=PHLBKPHSAVXXEF-UHFFFAOYSA-N; SMILES=Clc1cccc(c1)N1CCN(CCCn2nc3ccccn3c2=O)CC1; trazodona; trazodonum
xref: Beilstein:628010; CAS:19794-93-5; DrugBank:DB00656; Drug_Central:2717; KEGG:C07156; KEGG:D08626; LINCS:LSM-3580
xref_mesh: MESH:D014196
xref: Patent:US3381009; Wikipedia:Trazodone
G
Bmp6
bone morphogenetic protein 6
increases expression
ISO
Trazodone results in increased expression of BMP6 mRNA
CTD
PMID:32816093
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
G
Cat
catalase
affects activity
ISO
Trazodone affects the activity of CAT protein
CTD
PMID:19798453
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases activity
ISO
Trazodone results in decreased activity of CYP1B1 protein
CTD
PMID:33814510
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
EXP ISO
[SOD2 co-treated with CYP3A4] affects the susceptibility to Trazodone Trazodone inhibits the reaction [CYP3A4 protein results in increased oxidation of and results in increased activity of Haloperidol]
CTD
PMID:12584149 PMID:19501153
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
multiple interactions
ISO
Trazodone inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol]
CTD
PMID:12584149
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Ereg
epiregulin
increases expression
ISO
Trazodone results in increased expression of EREG mRNA
CTD
PMID:32816093
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
G
Htr1a
5-hydroxytryptamine receptor 1A
decreases expression affects binding increases expression
EXP ISO
Trazodone results in decreased expression of HTR1A protein Trazodone binds to HTR1A protein Trazodone results in increased expression of HTR1A protein
CTD
PMID:1589591 PMID:7855217 PMID:12127910
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
G
Htr2c
5-hydroxytryptamine receptor 2C
affects binding
ISO
Trazodone binds to HTR2C protein
CTD
PMID:18083778
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
G
Il1a
interleukin 1 alpha
increases expression
ISO
Trazodone results in increased expression of IL1A mRNA
CTD
PMID:32816093
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
increases expression
ISO
Trazodone results in increased expression of IL1B mRNA
CTD
PMID:32816093
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il24
interleukin 24
increases expression
ISO
Trazodone results in increased expression of IL24 mRNA
CTD
PMID:32816093
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Trazodone results in decreased activity of KCNH2 protein
CTD
PMID:15740727 PMID:26187900 PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Kcnq1
potassium voltage-gated channel subfamily Q member 1
decreases activity
ISO
Trazodone results in decreased activity of KCNQ1 protein
CTD
PMID:26187900
NCBI chr 1:198,291,711...198,624,683
Ensembl chr 1:198,291,766...198,624,669
G
Met
MET proto-oncogene, receptor tyrosine kinase
increases expression
ISO
Trazodone results in increased expression of MET mRNA
CTD
PMID:32816093
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP
Trazodone inhibits the reaction [endotoxin, Escherichia coli results in increased expression of NOS2 protein]; Trazodone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
CTD
PMID:17637181
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Pid1
phosphotyrosine interaction domain containing 1
increases expression
ISO
Trazodone results in increased expression of PID1 mRNA
CTD
PMID:32816093
NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:85,284,335...85,503,044
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions increases expression
EXP ISO
Trazodone inhibits the reaction [endotoxin, Escherichia coli results in increased expression of PTGS2 protein]; Trazodone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] Trazodone results in increased expression of PTGS2 mRNA
CTD
PMID:17637181 PMID:32816093
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Scn5a
sodium voltage-gated channel alpha subunit 5
decreases activity
ISO
Trazodone results in decreased activity of SCN5A protein
CTD
PMID:26187900
NCBI chr 8:119,220,905...119,318,816
Ensembl chr 8:119,220,905...119,318,769
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Trazodone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
Trazodone results in increased expression of SLC7A11 mRNA
CTD
PMID:32816093
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Slpi
secretory leukocyte peptidase inhibitor
increases expression
ISO
Trazodone results in increased expression of SLPI mRNA
CTD
PMID:32816093
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
G
Sod2
superoxide dismutase 2
multiple interactions
EXP
[SOD2 co-treated with CYP3A4] affects the susceptibility to Trazodone
CTD
PMID:19501153
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Tnfaip6
TNF alpha induced protein 6
increases expression
ISO
Trazodone results in increased expression of TNFAIP6 mRNA
CTD
PMID:32816093
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
G
Tnnt3
troponin T3, fast skeletal type
increases expression
EXP
Trazodone results in increased expression of TNNT3 protein
CTD
PMID:29774748
NCBI chr 1:197,652,535...197,669,736
Ensembl chr 1:197,652,431...197,669,535
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all